دورية أكاديمية

Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.

التفاصيل البيبلوغرافية
العنوان: Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
المؤلفون: Bunt J; Department of Oncogenomics, Academic Medical Center, Amsterdam, The Netherlands., Hasselt NE, Zwijnenburg DA, Koster J, Versteeg R, Kool M
المصدر: PloS one [PLoS One] 2011; Vol. 6 (10), pp. e26058. Date of Electronic Publication: 2011 Oct 10.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Cerebellar Neoplasms/*pathology , Gene Expression Regulation, Neoplastic/*genetics , Medulloblastoma/*pathology , Otx Transcription Factors/*metabolism , Promoter Regions, Genetic/*genetics , Proto-Oncogene Proteins c-myc/*metabolism, Cell Line, Tumor ; Cerebellar Neoplasms/genetics ; DNA/genetics ; DNA/metabolism ; Humans ; Medulloblastoma/genetics ; Nucleotide Motifs/genetics ; Protein Binding ; Stem Cells/metabolism ; Substrate Specificity ; Transcription Initiation Site
مستخلص: Both OTX2 and MYC are important oncogenes in medulloblastoma, the most common malignant brain tumor in childhood. Much is known about MYC binding to promoter regions, but OTX2 binding is hardly investigated. We used ChIP-on-chip data to analyze the binding patterns of both transcription factors in D425 medulloblastoma cells. When combining the data for all promoter regions in the genome, OTX2 binding showed a remarkable bi-modal distribution pattern with peaks around -250 bp upstream and +650 bp downstream of the transcription start sites (TSSs). Indeed, 40.2% of all OTX2-bound TSSs had more than one significant OTX2-binding peak. This OTX2-binding pattern was very different from the TSS-centered single peak binding pattern observed for MYC and other known transcription factors. However, in individual promoter regions, OTX2 and MYC have a strong tendency to bind in proximity of each other. OTX2-binding sequences are depleted near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding. This contrasts to the enrichment of E-box sequences at TSSs. Both OTX2 and MYC binding independently correlated with higher gene expression. Interestingly, genes of promoter regions with multiple OTX2 binding as well as MYC binding showed the highest expression levels in D425 cells and in primary medulloblastomas. Genes within this class of promoter regions were enriched for medulloblastoma and stem cell specific genes. Our data suggest an important functional interaction between OTX2 and MYC in regulating gene expression in medulloblastoma.
References: Biochem Biophys Res Commun. 2003 Jan 24;300(4):908-14. (PMID: 12559959)
Nat Rev Genet. 2009 Sep;10(9):605-16. (PMID: 19668247)
Mech Dev. 1999 Jul;85(1-2):97-102. (PMID: 10415350)
Cancer Res. 2005 Feb 1;65(3):919-24. (PMID: 15705891)
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6275-80. (PMID: 16606849)
Mol Endocrinol. 2000 Aug;14(8):1246-56. (PMID: 10935548)
Nucleic Acids Res. 2008 Aug;36(14):4549-64. (PMID: 18611952)
Nat Methods. 2007 Aug;4(8):651-7. (PMID: 17558387)
J Biol Chem. 2009 Jun 19;284(25):16966-16978. (PMID: 19401468)
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8472-7. (PMID: 15932940)
Physiol Genomics. 1999 Aug 31;1(2):83-91. (PMID: 11015565)
J Biol Chem. 2001 Jun 8;276(23):20482-90. (PMID: 11279041)
Nat Genet. 2008 Jul;40(7):897-903. (PMID: 18552846)
J Neuropathol Exp Neurol. 2006 Feb;65(2):176-86. (PMID: 16462208)
J Biol Chem. 2010 Aug 27;285(35):26933-26944. (PMID: 20530484)
J Pathol. 2009 May;218(1):86-94. (PMID: 19197950)
J Mol Med (Berl). 2006 Jul;84(7):604-15. (PMID: 16607563)
Hum Mol Genet. 2007 Oct 15;16(20):2433-52. (PMID: 17656371)
J Neurooncol. 2011 Mar;102(1):25-33. (PMID: 20607354)
PLoS One. 2008 Aug 28;3(8):e3088. (PMID: 18769486)
Genome Biol. 2003;4(5):P3. (PMID: 12734009)
Biotechniques. 2003 Feb;34(2):374-8. (PMID: 12613259)
Nat Genet. 2009 Apr;41(4):465-72. (PMID: 19270706)
Science. 2000 Dec 22;290(5500):2306-9. (PMID: 11125145)
Nat Genet. 2003 Jul;34(3):267-73. (PMID: 12808457)
Cell. 2007 May 18;129(4):823-37. (PMID: 17512414)
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. (PMID: 16199517)
Cell. 2006 May 19;125(4):801-14. (PMID: 16713569)
Arch Pathol Lab Med. 2002 May;126(5):540-4. (PMID: 11958658)
Mol Cancer Res. 2010 Oct;8(10):1344-57. (PMID: 21047732)
Cell. 2008 Jun 13;133(6):1106-17. (PMID: 18555785)
Cancer Res. 2010 Jan 1;70(1):181-91. (PMID: 20028867)
J Clin Oncol. 2009 Apr 1;27(10):1627-36. (PMID: 19255330)
Cell. 2010 Oct 15;143(2):313-24. (PMID: 20946988)
Mol Endocrinol. 2007 Feb;21(2):457-71. (PMID: 17095579)
FEBS Lett. 1999 Feb 19;445(1):160-4. (PMID: 10069392)
Science. 2002 Oct 18;298(5593):597-600. (PMID: 12228720)
Oncogene. 2003 Oct 23;22(48):7687-94. (PMID: 14576832)
J Clin Oncol. 2011 Apr 10;29(11):1424-30. (PMID: 21098324)
Cancer Res. 2005 Feb 1;65(3):703-7. (PMID: 15705863)
PLoS One. 2008;3(12):e3932. (PMID: 19079543)
Development. 2009 Oct;136(19):3311-22. (PMID: 19736326)
Mol Cell Biol. 2008 Apr;28(8):2732-44. (PMID: 18268006)
Mol Cell Biol. 2007 Jan;27(1):340-51. (PMID: 17060451)
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5408-13. (PMID: 18385377)
Int J Cancer. 2012 Jul 15;131(2):E21-32. (PMID: 21964830)
Biochem Biophys Res Commun. 2000 Jan 7;267(1):64-70. (PMID: 10623575)
المشرفين على المادة: 0 (MYC protein, human)
0 (OTX2 protein, human)
0 (Otx Transcription Factors)
0 (Proto-Oncogene Proteins c-myc)
9007-49-2 (DNA)
تواريخ الأحداث: Date Created: 20111022 Date Completed: 20120213 Latest Revision: 20211020
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3189962
DOI: 10.1371/journal.pone.0026058
PMID: 22016811
قاعدة البيانات: MEDLINE